Viewing Study NCT07042828


Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2026-01-01 @ 6:22 AM
Study NCT ID: NCT07042828
Status: COMPLETED
Last Update Posted: 2025-06-29
First Post: 2025-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions
Sponsor: Humanis Saglık Anonim Sirketi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module